Medical Research
(H30)
IRS Verified
DX Registered
990 on File
KAREN WYCKOFF REIN IN SARCOMA
Financial strength (30%)
45/100
Reliability (20%)
82/100
Effectiveness (25%)
60/100
Impact (25%)
No data yet
43
CharityAI™ Score
out of 100
Mission Statement
Our three-pronged mission: educating the public and medical community about sarcomas, supporting sarcoma patients and their loved ones, and funding research directed toward developing new treatments and finding a cure for sarcoma cancers.
Financial Overview — FY 2024
$785K
Annual Budget
$577K
Total Revenue
$697K
Total Expenses
$1.0M
Net Assets
4
Employees
Revenue Sources
Expense Breakdown
Program Expense Ratio
54.7%
Fundraising Efficiency
148.9%
Operating Reserve
17.86x
Liability-to-Asset
5.1%
Revenue Diversification
93.4%
Executive Compensation
$121K
Compared with Peers
FY 2025
Compared with 300 similar organizations
(United States, Medical Research, $100K–$1M in expenses), FY 2025.
This organization's figures are from FY 2024.
This organization
Middle half of peers (P25–P75)
Peer median
| Ratio | This org | Peer median | Position (P10 → P90) | |
|---|---|---|---|---|
|
Program expense ratio
Program expenses / total expenses
· higher is better
|
54.7% | 84.6% |
P10P90
|
Bottom quarter |
|
Admin expense ratio
Management and general / total expenses
· lower is better
|
25.5% | 10.0% |
P10P90
|
Bottom quarter |
|
Fundraising expense ratio
Fundraising expenses / total expenses
· lower is better
|
19.8% | 0.0% |
P10P90
|
Bottom quarter |
|
Fundraising efficiency
Fundraising expenses / gross fundraising income
· lower is better
|
148.9% | 10.1% |
P10P90
|
Bottom quarter |
|
Operating reserve
Months of expenses covered by net assets
· higher is better
|
17.9 mo | 11.7 mo |
P10P90
|
Above median |
|
Liabilities to assets
Total liabilities / total assets
· lower is better
|
5.1% | 0.0% |
P10P90
|
Below median |
|
Revenue concentration
Share of revenue from the largest source
· lower is better
|
93.4% | 92.2% |
P10P90
|
Below median |
|
Revenue growth
Year over year revenue growth
|
-4.8% | 3.4% |
P10P90
|
|
|
Expense growth
Year over year expense growth
|
25.8% | 7.5% |
P10P90
|
|
|
Surplus margin
Surplus as a share of revenue
|
-20.8% | -1.6% |
P10P90
|
CharityAI™ Evaluation — 2025
43 / 10045
Financial
62
Reliability
57
Effectiveness
10
Impact
Financial Strength (30%)
45
Reliability & Transparency (20%)
62
Program Effectiveness (25%)
57
Impact & Outcomes (25%)
10
0 programs
4 staff
IRS Verified 90% Data Complete
Financial History
| Year | Revenue | Expenses | Net Assets | Program % | Staff |
|---|---|---|---|---|---|
| 2024 | $577K | $697K | $1.0M | 54.7% | 4 |
| 2023 | $606K | $554K | $1.2M | 41.4% | 6 |
| 2022 | $717K | $737K | $1.1M | 69.5% | 4 |
| 2021 | $951K | $529K | $1.2M | 51.1% | 1 |
Donor Reviews
Write a ReviewNo reviews yet
Be the first to share your experience with this organization.